MedTrace Logo

Healthy Aging in People With Epilepsy Program

NCT06052605 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 380

Last updated 2026-06-12

No results posted yet for this study

Summary

The goal of this clinical trial is to develop and test an educational program about dementia in older adults living with epilepsy. The main questions it aims to answer are:

1. Can providing education on healthy aging, chronic disease management, dementia, and modifiable lifestyle dementia risk factors improve dementia knowledge and health literacy among older adults with epilepsy?
2. Can aging related education and resources improve quality of life among older adults with epilepsy?

Participants will:

* Be randomized to an intervention group or a control group.
* Complete a 12-week group educational program (intervention group).
* Complete pre- and post-program evaluation (intervention and control groups).

Conditions

Interventions

BEHAVIORAL

Healthy Aging in People with Epilepsy Program

This a 12-week group educational program providing education on healthy aging, chronic disease management, dementia, and modifiable lifestyle dementia risk factors.

OTHER

Patient Survey

Patients with receive an online survey to identify barriers in accessing geriatric care, target educational topics, and concerns about aging. Additionally, they will be surveyed on unmet needs in their care, availability of healthcare information and resources related to aging and dementia, and elements of the program most important to them.

OTHER

Provider Survey

Providers will receive an online survey to identify barriers in accessing geriatric care, target educational topics, and concerns about aging.

Sponsors & Collaborators

  • National Institute of Neurological Disorders and Stroke (NINDS)

    collaborator NIH

  • Anny Reyes

    lead OTHER

Principal Investigators

  • Anny Reyes, PhD · The Cleveland Clinic

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
55 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-03-25
Primary Completion
2030-07-31
Completion
2030-08-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06052605 on ClinicalTrials.gov